CA-125 SERUM LEVELS IN THE EARLY POSTOPERATIVE PERIOD DO NOT REFLECT TUMOR REDUCTION OBTAINED BY CYTOREDUCTIVE SURGERY

被引:33
作者
YEDEMA, CA
KENEMANS, P
THOMAS, CM
MASSUGER, LF
WOBBES, T
VERSTRAETEN, R
VANKAMP, GJ
HILGERS, J
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT OBSTET & GYNAECOL,DE BOELELAAN 1117,1007 MB AMSTERDAM,NETHERLANDS
[2] UNIV HOSP NIJMEGEN,NIJMEGEN,NETHERLANDS
[3] UNIV HOSP NIJMEGEN,DEPT OBSTET & GYNAECOL,NIJMEGEN,NETHERLANDS
[4] UNIV HOSP NIJMEGEN,DEPT SURG,NIJMEGEN,NETHERLANDS
[5] FREE UNIV AMSTERDAM HOSP,DEPT CLIN CHEM,AMSTERDAM,NETHERLANDS
关键词
D O I
10.1016/S0959-8049(05)80203-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to assess whether A. 125 serum level reflect the outcome of cytoreductive surgery, CA 125 antigen levels were determined prior to and after debulking surgery in 50 ovarian cancer patients and compared to CA 125 serum levels before and after surgery in a control group of 140 patients undergoing laparotomy for various malignant or benign diseases. A significant CA 125 decrease in the first post-operative week was seen in 56% of ovarian cancer patients whereas 26% remained stable and 18% showed a significant increase after surgery. Although removal of tumour had been complete in all 14 stage I-II ovarian carcinomas, only 2 of these patients showed a subsequent significant CA 125 decrease after cytoreductive surgery, while 4 patients showed a significant increase. Such increases of CA 125 following surgery were also seen in uterine carcinomas (30%), in gastrointestinal carcinomas (75%) and in patients after laparotomy for benign gynaecological diseases (23%). CA 125 pre-treatment levels were significantly lower in patients with post-operative increases than in patients with stable or decreasing CA 125 patterns. Patients with stable CA 125 levels also had lower CA 125 pretreatment levels compared to patients with a post-operative CA 125 decrease. Post-operative increases were observed for at least 2 weeks after debulking in the case of ovarian cancer. Pre-operative levels of these patients were either within the normal range or moderately elevated. Serial measurements during surgery in partial debulking showed a rapid CA 125 decline within 24 h followed by increasing CA 125 values thereafter. Our data indicate that CA 125 serum levels in the direct post-operative period do not always reflect the outcome of cytoreductive surgery. There appears to be an effect on CA 125 levels caused by the abdominal surgical procedure itself. Consequently, CA 125 levels after abdominal surgery should be interpreted with caution.
引用
收藏
页码:966 / 971
页数:6
相关论文
共 26 条
[1]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[2]   MONOCLONAL-ANTIBODIES THAT DISCRIMINATE BETWEEN HUMAN OVARIAN CARCINOMAS AND BENIGN OVARIAN-TUMORS [J].
BOERMAN, OC ;
MAKKINK, WK ;
THOMAS, CMG ;
HANSELAAR, AGJM ;
YEDEMA, CA ;
KENEMANS, P ;
POELS, LG .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) :117-127
[3]   DOES INTRAPERITONEAL CA-125 REFLECT DISEASE STATUS [J].
BULLER, RE ;
MANETTA, A ;
BLOSS, JD ;
DISAIA, PJ ;
BERMAN, ML .
GYNECOLOGIC ONCOLOGY, 1991, 40 (01) :66-69
[4]   OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].
CANNEY, PA ;
MOORE, M ;
WILKINSON, PM ;
JAMES, RD .
BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769
[5]   THE CLINICAL-SIGNIFICANCE OF PREOPERATIVE SERUM CA-125 IN OVARIAN-CANCER [J].
CRUICKSHANK, DJ ;
FULLERTON, WT ;
KLOPPER, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (07) :692-695
[6]   SERUM CA-125 LEVELS IN PATIENTS WITH A PROVISIONAL DIAGNOSIS OF PELVIC INFLAMMATORY DISEASE - CLINICAL AND THEORETICAL IMPLICATIONS [J].
DUK, JM ;
KAUER, FM ;
FLEUREN, GJ ;
DEBRUIJN, HWA .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1989, 68 (07) :637-641
[7]  
FLEUREN GJ, 1987, CANCER, V60, P2437, DOI 10.1002/1097-0142(19871115)60:10<2437::AID-CNCR2820601015>3.0.CO
[8]  
2-K
[9]   CLINICAL-SIGNIFICANCE OF SERUM CA125 VALUES IN PATIENTS WITH CANCERS OF THE DIGESTIVE-SYSTEM [J].
HAGA, Y ;
SAKAMOTO, K ;
EGAMI, H ;
YOSHIMURA, R ;
MORI, K ;
AKAGI, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1986, 292 (01) :30-34
[10]  
HALILA H, 1986, CANCER, V57, P1327, DOI 10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO